Rayont IncOver The Counter Market:RAYT
- LAST PRICE0.0005
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0005
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rayont Inc | 25.1K | 0.0x | --- |
Infinity Pharmaceuticals Inc | 90.0 | 0.0x | --- |
Humanigen Inc | 23.8K | 0.0x | --- |
Antigenics Inc | 2.4K | 0.0x | --- |
DNAPrint Genomics Inc | 640.0 | 0.0x | --- |
Adynxx Inc | 10.0 | 0.0x | --- |
Company Information
Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.
Contact Information
- Headquarters
- 228 HAMILTON AVENUE, 3RD FLOORPALO ALTO, CA, United States 94301
- Phone
- 626-262-7379
- Fax
- 630-288-4600
Executives
- Independent Chairman of the Board
- Bedri Thartori
- President, Chief Executive Officer, Chief Financial Officer, Director
- Marshini Thulkanam
- Executive Director, Company Secretary
- Dhurata Toli
- Director
- Thea Dillon
- Director
- Jason Sunstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.1K |
|---|---|
Revenue (TTM) | $4.8M |
Shares Outstanding | 50.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.69 |
EPS | $0.02 |
Book Value | $0.11 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | -16.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
